Spruce Biosciences Inc. Gains 20.55%
Thu, Jun 02, 2022 at 05:30 PM
Spruce Biosciences Inc. (SPRB:NASDAQ) soared at $1.76, a gain of 20.5%. On Wed, Jun 01, 2022, SPRB:NASDAQ hit a New 2-Week Intraday High of $1.61. The stock appeared on our News Catalysts scanner on Wed, Jun 01, 2022 at 04:14 PM in the 'MISCELLANEOUS' category. From Thu, May 19, 2022, the stock recorded 50.00% Up Days and 33.33% Green Days
The stock spiked on Fri, Dec 17, 2021 at $5.8 with a volume of 114M+.
About Spruce Biosciences Inc. (SPRB:NASDAQ)
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders.
Top 10 Gainers:
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 47.48%
- Repare Therapeutics Inc. (RPTX:NASDAQ), 44.8%
- Esports Technologies Inc. (EBET:NASDAQ), 33.58%
- Immix Biopharma Inc. (IMMX:NASDAQ), 29.19%
- Credo Technology Group Holding Ltd (CRDO:NASDAQ), 26.24%
- Chewy, Inc. (CHWY:NYSE), 24.22%
- Integrated Media Technology Limited (IMTE:NASDAQ), 23.69%
- The Singing Machine Company Inc. (MICS:NASDAQ), 22.54%
- Spruce Biosciences Inc. (SPRB:NASDAQ), 20.55%
- PyroGenesis (PYR:NASDAQ), 19.92%